“regenxbio” Archives

in
Entry Author Date Location
Biotech Roundup: Gottlieb v. Juul, Solid Slumps, Avidity Gets $100M & More 11/15/19 National
Passage Bio Gets $116M As Wilson, Yamada Team Up On Gene Therapy Again 02/14/19 National
15 for ’19: Key Clinical Data to Watch for Next Year (Part 1) 12/17/18 National
Bio Roundup: Midterm Fallout, Alzheimer’s Search, Postpartum Panel 11/09/18 National
Bio Roundup: Medicare Drug Prices, FDA Moves, Gene Therapy News & More 08/10/18 National
Ultragenyx Sweetens Offer, Dimension Tx Agrees to $151M Acquisition 10/03/17 San Francisco
Bio Roundup: RNAi’s Big Day, CAR-T For Kids, Drugs From Fungi & More 09/22/17 National
Ultragenyx Makes Competing Bid for Gene Therapy Biotech Dimension Tx 09/18/17 San Francisco
Bio Roundup: CAR-T’s Huge Week, Merck’s ‘Pib Choice & More 09/01/17 National
RegenxBio to Acquire Dimension Tx in Combo of Gene Therapy Companies 08/25/17 Boston
For Parkinson’s, Two New Drugs Coming As Prevail Gets Started in NY 08/09/17 New York
Audentes Prices $75M IPO As Gene Therapy Eyes First U.S. Approval 07/20/16 San Francisco
Biogen Turns To UPenn Gene Therapy Pioneers in Wide-Ranging Alliance 05/16/16 Boston
With $43.5M Startup Cash, Homology Med Chases New Gene Editing Twist 05/02/16 Boston
Biogen Helps Put $42.5M Into a Father’s Duchenne Gene Therapy Quest 11/05/15 Boston
Gene Therapy Startup Dimension Cuts Price But Bags $72M in IPO 10/21/15 Boston
Voyager Charts an IPO Course Amid Choppy Biotech Waters 10/11/15 Boston
No Drug Yet In Clinic, But CytomX Raises $80M In Discounted IPO 10/08/15 San Francisco
Amid Biotech Swoon, Third Rock’s MyoKardia Tees up IPO 09/28/15 San Francisco
East Coast Biotech Roundup: CAR-T, Celgene, Aerie, ITCI, IPOs, & More 09/21/15 Boston
Gene Therapy Startup Dimension Tx Takes Crossover Cash to IPO Queue 09/14/15 Boston
In Biotech, Everyone’s Going Public. What’s Your Excuse? 07/22/15 National
East Coast Biotech Roundup: Forum, Crossovers, Immuno-Oncology & More 04/24/15 Boston
Page 1 of 1